Anavex Life Sciences Corp (AVXL)

[blu_1]

Doc I fear is stuck in the past and thinks the FDA operates the same way it did back in the 1980's. This is the 2020's and the FDA aims to be more efficient and expedite drugs to market, especially for diseases w/unmet need. I think Excellence won't be need. Anavex changed that Avatar to a Ph3 trial for a reason, which is fast track to approval.